RMD
RESMED INC
Company overview
- Market capitalization
- —
- Employees
- 10,600
- Latest publication
- 2026-09-29
About RESMED INC
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Financial statements
Income Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,653,443,000USD | 5,146,327,000USD | 4,685,297,000USD | 4,222,993,000USD | 3,578,127,000USD | 3,196,825,000USD | 2,957,013,000USD | 2,606,572,000USD |
| Cost Of Revenue | 2,201,704,000USD | 2,091,357,000USD | 2,029,994,000USD | 1,867,331,000USD | 1,553,816,000USD | 1,357,725,000USD | 1,239,227,000USD | 1,069,987,000USD |
| Gross Profit | 3,451,739,000USD | 3,054,970,000USD | 2,655,303,000USD | 2,355,662,000USD | 2,024,311,000USD | 1,839,100,000USD | 1,717,786,000USD | 1,536,585,000USD |
| Research Development | 378,285,000USD | 331,284,000USD | 307,525,000USD | 287,642,000USD | 253,575,000USD | 225,284,000USD | 201,946,000USD | 180,651,000USD |
| Selling General Administrative | 1,119,528,000USD | 991,019,000USD | 917,136,000USD | 874,003,000USD | 739,372,000USD | 670,387,000USD | 676,689,000USD | 645,010,000USD |
| Other Operating Expenses | 67,211,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 1,565,024,000USD | 1,369,607,000USD | 1,335,410,000USD | 1,223,791,000USD | 1,024,025,000USD | 935,422,000USD | 908,727,000USD | 957,322,000USD |
| Operating Income | 1,886,715,000USD | 1,685,363,000USD | 1,319,893,000USD | 1,131,871,000USD | 1,000,286,000USD | 903,678,000USD | 809,659,000USD | 579,263,000USD |
| Total Other Income Expense Net | 32,701,000USD | -7,797,000USD | -55,095,000USD | -30,207,000USD | -39,803,000USD | -20,016,000USD | -76,571,000USD | -60,416,000USD |
| Income Before Tax | 1,919,416,000USD | 1,677,566,000USD | 1,264,798,000USD | 1,101,664,000USD | 960,483,000USD | 883,662,000USD | 733,088,000USD | 518,847,000USD |
| Income Tax Expense | 396,123,000USD | 276,843,000USD | 243,847,000USD | 204,108,000USD | 181,046,000USD | 409,157,000USD | 111,414,000USD | 114,255,000USD |
| Equity Method Income Loss | 6,955,000USD | — | — | — | — | — | — | — |
| Net Income | 1,523,293,000USD | 1,400,723,000USD | 1,020,951,000USD | 897,556,000USD | 779,437,000USD | 474,505,000USD | 621,674,000USD | 404,592,000USD |
| Net Income Applicable To Common Shares | 1,523,293,000USD | 1,400,723,000USD | 1,020,951,000USD | 897,556,000USD | 779,437,000USD | 780,392,000USD | 621,674,000USD | 404,592,000USD |
| Unclassified Operating Expenses | — | 47,304,000USD | 110,749,000USD | 62,146,000USD | 31,078,000USD | 39,751,000USD | 30,092,000USD | 131,661,000USD |
| Interest Income | — | 2,541,000USD | 51,601,000USD | 44,722,000USD | 43,000,000USD | 34,832,000USD | 63,083,000USD | 2,299,000USD |
| Interest Expense | — | 12,609,000USD | 45,708,000USD | 47,379,000USD | 22,312,000USD | 23,989,000USD | 40,377,000USD | 36,156,000USD |
| Net Interest Income | — | 4,114,000USD | -45,708,000USD | -47,379,000USD | -22,312,000USD | -23,627,000USD | -39,356,000USD | -33,857,000USD |
| Tax Provision | — | 276,843,000USD | 243,847,000USD | 204,108,000USD | 181,046,000USD | 409,157,000USD | 111,414,000USD | 114,255,000USD |
| Net Income From Continuing Ops | — | 1,400,723,000USD | 1,020,951,000USD | 897,556,000USD | 779,437,000USD | 474,505,000USD | 621,674,000USD | 404,592,000USD |
| Ebit | — | 1,677,566,000USD | 1,317,334,000USD | 1,162,279,000USD | 982,795,000USD | 912,351,000USD | 809,059,000USD | 555,003,000USD |
| Ebitda | — | 1,913,377,000USD | 1,533,543,000USD | 1,358,801,000USD | 1,176,636,000USD | 1,103,869,000USD | 990,432,000USD | 705,798,000USD |
| Depreciation And Amortization | — | 235,811,000USD | 216,209,000USD | 196,522,000USD | 193,841,000USD | 191,518,000USD | 181,373,000USD | 150,795,000USD |
| Reconciled Depreciation | — | 235,811,000USD | 216,209,000USD | 197,562,000USD | 193,841,000USD | 191,518,000USD | 181,373,000USD | 150,795,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | -36,194,000USD | -24,260,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,431,406,000USD | 1,422,808,000USD | 1,335,582,000USD | 1,347,993,000USD | 1,291,736,000USD | 1,282,089,000USD | 1,224,509,000USD | 1,223,195,000USD |
| Cost Of Revenue | 540,427,000USD | 538,148,000USD | 514,762,000USD | 527,923,000USD | 525,328,000USD | 530,814,000USD | 507,290,000USD | 518,930,000USD |
| Gross Profit | 890,979,000USD | 884,660,000USD | 820,820,000USD | 820,070,000USD | 766,408,000USD | 751,275,000USD | 717,219,000USD | 704,265,000USD |
| Research Development | 94,267,000USD | 90,969,000USD | 87,323,000USD | 86,443,000USD | 83,944,000USD | 81,373,000USD | 79,524,000USD | 80,861,000USD |
| Selling General Administrative | 285,655,000USD | 278,396,000USD | 259,194,000USD | 265,125,000USD | 245,302,000USD | 241,613,000USD | 238,979,000USD | 242,188,000USD |
| Unclassified Operating Expenses | 11,247,000USD | 17,700,000USD | 27,766,000USD | 13,959,000USD | 10,893,000USD | 11,047,000USD | 11,404,000USD | — |
| Total Operating Expenses | 391,169,000USD | 387,065,000USD | 374,283,000USD | 365,527,000USD | 340,139,000USD | 334,033,000USD | 329,907,000USD | 323,048,000USD |
| Operating Income | 499,810,000USD | 497,595,000USD | 446,537,000USD | 454,540,000USD | 426,268,000USD | 417,243,000USD | 387,312,000USD | 381,217,000USD |
| Interest Expense | 12,287,000USD | 7,949,000USD | 8,793,000USD | 5,757,000USD | 3,183,000USD | 4,788,000USD | 5,502,000USD | 9,550,000USD |
| Net Interest Income | 12,287,000USD | 7,949,000USD | 8,793,000USD | 5,757,000USD | 793,000USD | -775,000USD | -1,661,000USD | -5,921,000USD |
| Income Before Tax | 502,312,000USD | 496,147,000USD | 446,793,000USD | 458,053,000USD | 417,693,000USD | 418,322,000USD | 383,497,000USD | 357,732,000USD |
| Income Tax Expense | 103,580,000USD | 103,554,000USD | 98,257,000USD | 78,348,000USD | 52,652,000USD | 73,700,000USD | 72,142,000USD | 65,495,000USD |
| Tax Provision | 103,580,000USD | 103,555,000USD | 98,257,000USD | 78,348,000USD | 52,652,000USD | 73,700,000USD | 72,142,000USD | 65,496,000USD |
| Net Income | 398,732,000USD | 392,593,000USD | 348,536,000USD | 379,705,000USD | 365,041,000USD | 344,622,000USD | 311,355,000USD | 292,236,000USD |
| Net Income From Continuing Ops | 398,732,000USD | 392,593,000USD | 348,536,000USD | 379,705,000USD | 365,041,000USD | 344,622,000USD | 311,355,000USD | 292,236,000USD |
| Ebit | 514,599,000USD | 504,096,000USD | 455,586,000USD | 458,053,000USD | 417,693,000USD | 423,110,000USD | 388,999,000USD | 307,602,000USD |
| Ebitda | 583,631,000USD | 566,426,000USD | 503,284,000USD | 532,341,000USD | 469,603,000USD | 479,012,000USD | 442,709,000USD | 362,356,000USD |
| Depreciation And Amortization | 69,032,000USD | 62,330,000USD | 47,698,000USD | 74,288,000USD | 51,910,000USD | 55,902,000USD | 53,710,000USD | 54,754,000USD |
| Reconciled Depreciation | 69,032,000USD | 62,330,000USD | 57,669,000USD | 74,288,000USD | 51,911,000USD | 55,902,000USD | 53,710,000USD | 54,755,000USD |
| Total Other Income Expense Net | 2,502,000USD | -1,447,000USD | 256,000USD | 3,513,000USD | -8,575,000USD | 1,079,000USD | -3,815,000USD | -23,484,000USD |
| Interest Income | — | 9,770,000USD | 4,092,000USD | 4,493,000USD | 4,519,000USD | 1,137,000USD | 1,378,000USD | — |
| Net Income Applicable To Common Shares | — | 392,593,000USD | 348,536,000USD | 379,705,000USD | 365,041,000USD | 344,622,000USD | 311,355,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 8,965,950,000USD | 8,174,391,000USD | 6,872,394,000USD | 6,751,708,000USD | 5,095,853,000USD | 4,728,125,000USD | 4,587,376,000USD | 4,107,682,000USD |
| Cash And Equivalents | 1,469,234,000USD | 1,209,450,000USD | 238,361,000USD | 227,891,000USD | 273,710,000USD | 295,278,000USD | 463,156,000USD | 147,128,000USD |
| Total Current Assets | 4,324,739,000USD | 3,505,605,000USD | 2,357,719,000USD | 2,367,830,000USD | 1,931,478,000USD | 1,574,757,000USD | 1,523,459,000USD | 1,145,366,000USD |
| Other Current Assets | 416,081,000USD | 377,777,000USD | 459,833,000USD | 437,018,000USD | 337,908,000USD | 197,261,000USD | 168,745,000USD | 120,113,000USD |
| Other Non Current Assets | 214,649,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 2,380,557,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 1,395,110,000USD | 1,019,120,000USD | 910,655,000USD | 758,533,000USD | 689,299,000USD | 911,766,000USD | 602,761,000USD | 555,991,000USD |
| Other Current Liabilities | 494,921,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 213,028,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 6,585,393,000USD | 5,967,859,000USD | 4,864,043,000USD | 4,129,903,000USD | 3,360,751,000USD | 2,885,679,000USD | 2,497,027,000USD | 2,072,193,000USD |
| Total Equity Including Noncontrolling Interest | 6,585,393,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 659,365,000USD | 9,900,000USD | 9,900,000USD | 9,902,000USD | 9,916,000USD | 12,000,000USD | 11,987,000USD | 11,992,000USD |
| Long Term Debt | 399,415,000USD | 658,392,000USD | 697,313,000USD | 1,431,234,000USD | 765,325,000USD | 643,351,000USD | 1,164,133,000USD | 1,258,861,000USD |
| Deferred Revenue | 162,911,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 170,951,000USD | — | — | — | — | — | — | — |
| Net Receivables | 1,036,233,000USD | 990,667,000USD | 837,275,000USD | 704,909,000USD | 575,950,000USD | 625,185,000USD | 474,643,000USD | 528,484,000USD |
| Inventory | 945,805,000USD | 927,711,000USD | 822,250,000USD | 998,012,000USD | 743,910,000USD | 457,033,000USD | 416,915,000USD | 349,641,000USD |
| Property Plant Equipment Net | 734,996,000USD | 718,287,000USD | 699,146,000USD | 665,811,000USD | 630,495,000USD | 592,065,000USD | 535,683,000USD | 387,460,000USD |
| Goodwill | 2,909,575,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 452,737,000USD | 464,861,000USD | 485,904,000USD | 552,341,000USD | 345,944,000USD | 392,582,000USD | 448,168,000USD | 521,950,000USD |
| Accounts Payable | 308,923,000USD | 278,157,000USD | 237,728,000USD | 150,756,000USD | 159,245,000USD | 138,008,000USD | 135,786,000USD | 115,725,000USD |
| Short Term Debt | 259,950,000USD | 40,406,000USD | 35,178,000USD | 31,821,000USD | 31,772,000USD | 35,585,000USD | 33,250,000USD | 11,992,000USD |
| Common Stock | 764,000USD | 761,000USD | 588,000USD | 588,000USD | 586,000USD | 583,000USD | 580,000USD | 575,000USD |
| Retained Earnings | 7,255,121,000USD | 6,081,490,000USD | 4,991,647,000USD | 4,253,016,000USD | 3,613,736,000USD | 3,079,640,000USD | 2,832,991,000USD | 2,436,410,000USD |
| Accumulated Other Comprehensive Income | -82,515,000USD | -74,699,000USD | -251,529,000USD | -272,528,000USD | -312,747,000USD | -193,487,000USD | -283,982,000USD | -253,009,000USD |
| Total Liab | — | 2,206,532,000USD | 2,008,351,000USD | 2,621,805,000USD | 1,735,102,000USD | 1,842,446,000USD | 2,090,349,000USD | 2,035,489,000USD |
| Other Current Liab | — | 534,527,000USD | 377,678,000USD | 365,660,000USD | 344,722,000USD | 320,599,000USD | 270,353,000USD | 266,359,000USD |
| Capital Stock | — | 761,000USD | 588,000USD | 588,000USD | 586,000USD | 583,000USD | 580,000USD | 575,000USD |
| Good Will | — | 3,046,680,000USD | 2,842,055,000USD | 2,770,299,000USD | 1,936,442,000USD | 1,927,901,000USD | 1,890,324,000USD | 1,856,449,000USD |
| Other Assets | — | 438,958,000USD | 403,658,000USD | 261,313,000USD | 202,286,000USD | 240,820,000USD | 145,600,000USD | 144,354,000USD |
| Cash | — | 1,209,450,000USD | 238,361,000USD | 227,891,000USD | 273,710,000USD | 295,278,000USD | 463,156,000USD | 147,128,000USD |
| Cash And Short Term Investments | — | 1,209,450,000USD | 238,361,000USD | 227,891,000USD | 273,710,000USD | 295,278,000USD | 463,156,000USD | 147,128,000USD |
| Current Deferred Revenue | — | 166,030,000USD | 152,554,000USD | 138,072,000USD | 108,667,000USD | 109,611,000USD | 98,617,000USD | 88,667,000USD |
| Net Debt | — | -357,637,000USD | 635,574,000USD | 1,352,017,000USD | 643,840,000USD | 498,437,000USD | 836,107,000USD | 1,123,725,000USD |
| Short Long Term Debt Total | — | 851,813,000USD | 873,935,000USD | 1,579,908,000USD | 917,550,000USD | 793,715,000USD | 1,299,263,000USD | 1,270,853,000USD |
| Short Term Investments | — | 13,080,000USD | 12,026,000USD | 12,423,000USD | 9,167,000USD | — | — | — |
| Property Plant Equipment Gross | — | 1,423,595,000USD | 1,426,113,000USD | 665,811,000USD | 630,495,000USD | 592,065,000USD | 535,683,000USD | 387,460,000USD |
| Common Stock Shares Outstanding | — | 147,340,000shares | 147,550,000shares | 147,455,000shares | 147,043,000shares | 146,451,000shares | 145,652,000shares | 144,484,000shares |
| Non Current Assets Total | — | 4,668,786,000USD | 4,514,675,000USD | 4,383,878,000USD | 3,164,375,000USD | 3,153,368,000USD | 3,063,917,000USD | 2,962,316,000USD |
| Non Current Liabilities Total | — | 1,187,412,000USD | 1,097,696,000USD | 1,863,272,000USD | 1,045,803,000USD | 930,680,000USD | 1,487,588,000USD | 1,479,498,000USD |
| Non Current Liabilities Other | — | 141,520,000USD | 42,257,000USD | 68,166,000USD | 5,974,000USD | 6,802,000USD | 8,347,000USD | 209,257,000USD |
| Non Currrent Assets Other | — | 100,806,000USD | 114,235,000USD | 105,559,000USD | 104,533,000USD | 85,462,000USD | 97,578,000USD | 94,284,000USD |
| Net Working Capital | — | 2,486,485,000USD | 1,447,064,000USD | 1,609,297,000USD | 1,242,179,000USD | 662,991,000USD | 920,698,000USD | 589,375,000USD |
| Unclassified Non Current Assets | — | -100,806,000USD | — | — | -55,325,000USD | -85,462,000USD | -53,436,000USD | -94,281,000USD |
| Unclassified Non Current Liabilities | — | 387,500,000USD | 358,126,000USD | 48,687,000USD | 114,479,000USD | 107,977,000USD | 80,522,000USD | -220,637,000USD |
| Unclassified Current Liabilities | — | — | 97,617,000USD | 62,322,000USD | 34,977,000USD | 295,963,000USD | 52,768,000USD | 61,256,000USD |
| Unclassified Equity | — | — | 122,749,000USD | 148,239,000USD | 58,590,000USD | 1,621,616,000USD | 1,570,114,000USD | 1,510,898,000USD |
| Other Liab | — | — | — | 315,185,000USD | 160,025,000USD | 172,550,000USD | 221,575,000USD | 220,637,000USD |
| Net Tangible Assets | — | — | — | 807,263,000USD | 1,078,365,000USD | 565,196,000USD | 158,535,000USD | -306,206,000USD |
| Treasury Stock | — | — | — | — | — | -1,623,256,000USD | -1,623,256,000USD | -1,623,256,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | 13,011,000USD | 11,380,000USD |
| Long Term Investments | — | — | — | — | — | — | — | 52,100,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 8,784,285,000USD | 8,503,370,000USD | 8,308,352,000USD | 8,174,391,000USD | 7,566,822,000USD | 7,141,334,000USD | 7,222,417,000USD | 6,872,394,000USD |
| Intangible Assets | 425,185,000USD | 430,240,000USD | 447,067,000USD | 464,861,000USD | 430,109,000USD | 438,003,000USD | 478,613,000USD | 485,904,000USD |
| Other Current Assets | 445,730,000USD | 423,319,000USD | 337,663,000USD | 377,777,000USD | 461,421,000USD | 472,377,000USD | 485,584,000USD | 421,650,000USD |
| Total Liab | 2,292,374,000USD | 2,182,491,000USD | 2,187,088,000USD | 2,206,532,000USD | 2,020,689,000USD | 1,888,325,000USD | 2,027,391,000USD | 2,008,351,000USD |
| Total Stockholder Equity | 6,491,911,000USD | 6,320,879,000USD | 6,121,264,000USD | 5,967,859,000USD | 5,546,133,000USD | 5,253,009,000USD | 5,195,026,000USD | 4,864,043,000USD |
| Other Current Liab | 446,149,000USD | 391,500,000USD | 395,833,000USD | 402,253,000USD | 386,325,000USD | 352,541,000USD | 365,749,000USD | 377,678,000USD |
| Common Stock | 763,000USD | 763,000USD | 762,000USD | 761,000USD | 761,000USD | 760,000USD | 758,000USD | 588,000USD |
| Capital Stock | 763,000USD | 763,000USD | 762,000USD | 761,000USD | 761,000USD | 760,000USD | 758,000USD | 588,000USD |
| Retained Earnings | 6,958,779,000USD | 6,647,285,000USD | 6,342,276,000USD | 6,081,490,000USD | 5,779,375,000USD | 5,492,038,000USD | 5,225,111,000USD | 4,991,647,000USD |
| Good Will | 3,043,136,000USD | 3,044,370,000USD | 3,044,123,000USD | 3,046,680,000USD | 2,848,921,000USD | 2,805,353,000USD | 2,886,017,000USD | 2,842,055,000USD |
| Cash | 1,660,513,000USD | 1,417,069,000USD | 1,383,848,000USD | 1,209,450,000USD | 932,711,000USD | 521,944,000USD | 426,361,000USD | 238,361,000USD |
| Cash And Short Term Investments | 1,660,513,000USD | 1,426,393,000USD | 1,383,848,000USD | 1,209,450,000USD | 944,842,000USD | 521,944,000USD | 426,361,000USD | 238,361,000USD |
| Total Current Assets | 4,064,062,000USD | 3,818,801,000USD | 3,625,736,000USD | 3,505,605,000USD | 3,208,420,000USD | 2,836,177,000USD | 2,641,125,000USD | 2,357,719,000USD |
| Total Current Liabilities | 1,351,210,000USD | 1,248,114,000USD | 1,255,502,000USD | 1,019,120,000USD | 940,516,000USD | 851,960,000USD | 904,079,000USD | 910,655,000USD |
| Current Deferred Revenue | 179,277,000USD | 176,050,000USD | 167,777,000USD | 166,030,000USD | 160,445,000USD | 156,508,000USD | 157,188,000USD | 152,554,000USD |
| Net Debt | -817,344,000USD | -415,215,000USD | -537,496,000USD | -357,637,000USD | -92,939,000USD | 317,792,000USD | 423,881,000USD | 635,574,000USD |
| Short Term Debt | 289,161,000USD | 289,665,000USD | 289,874,000USD | 40,406,000USD | 38,655,000USD | 37,718,000USD | 38,174,000USD | 35,178,000USD |
| Short Long Term Debt | 259,928,000USD | 259,906,000USD | 259,899,000USD | 9,900,000USD | 9,906,000USD | 9,906,000USD | 9,896,000USD | 9,900,000USD |
| Short Long Term Debt Total | 843,169,000USD | 1,001,854,000USD | 846,352,000USD | 851,813,000USD | 839,772,000USD | 839,736,000USD | 850,242,000USD | 873,935,000USD |
| Long Term Debt | 404,168,000USD | 403,923,000USD | 408,661,000USD | 658,392,000USD | 663,126,000USD | 662,859,000USD | 667,578,000USD | 697,313,000USD |
| Short Term Investments | 5,475,000USD | 9,324,000USD | 8,018,000USD | 13,080,000USD | 12,131,000USD | — | — | 12,026,000USD |
| Net Receivables | 1,045,943,000USD | 1,047,044,000USD | 958,419,000USD | 990,667,000USD | 939,516,000USD | 959,753,000USD | 811,198,000USD | 875,458,000USD |
| Inventory | 911,876,000USD | 922,045,000USD | 945,806,000USD | 927,711,000USD | 862,641,000USD | 882,103,000USD | 917,982,000USD | 822,250,000USD |
| Accounts Payable | 273,301,000USD | 250,406,000USD | 266,775,000USD | 278,157,000USD | 222,561,000USD | 220,313,000USD | 249,278,000USD | 237,728,000USD |
| Property Plant Equipment Net | 728,574,000USD | 730,170,000USD | 725,636,000USD | 718,287,000USD | 687,942,000USD | 671,174,000USD | 717,279,000USD | 699,146,000USD |
| Property Plant Equipment Gross | 1,507,828,000USD | 1,478,132,000USD | 1,448,673,000USD | 1,423,595,000USD | 1,385,836,000USD | 1,365,353,000USD | 1,482,033,000USD | 1,426,113,000USD |
| Accumulated Other Comprehensive Income | -24,905,000USD | -29,863,000USD | -60,716,000USD | -74,699,000USD | -250,856,000USD | -298,890,000USD | -132,155,000USD | -251,529,000USD |
| Common Stock Shares Outstanding | 147,037,000shares | 147,037,000shares | 147,037,000shares | 147,037,000shares | 147,220,000shares | 147,599,000shares | 147,599,000shares | 147,533,000shares |
| Non Current Assets Total | 4,720,223,000USD | 4,684,569,000USD | 4,682,616,000USD | 4,668,786,000USD | 4,358,402,000USD | 4,305,157,000USD | 4,581,292,000USD | 4,514,675,000USD |
| Non Current Liabilities Total | 941,164,000USD | 934,377,000USD | 931,586,000USD | 1,187,412,000USD | 1,080,173,000USD | 1,036,365,000USD | 1,123,312,000USD | 1,097,696,000USD |
| Non Current Liabilities Other | 146,079,000USD | 138,538,000USD | 138,181,000USD | 141,520,000USD | 48,983,000USD | 10,831,000USD | 83,270,000USD | 42,257,000USD |
| Non Currrent Assets Other | -172,492,000USD | 35,334,000USD | 25,340,000USD | 100,806,000USD | 257,156,000USD | 12,573,000USD | 111,711,000USD | 114,235,000USD |
| Net Working Capital | 2,712,852,000USD | 2,570,687,000USD | 2,370,234,000USD | 2,486,485,000USD | 2,267,904,000USD | 1,984,217,000USD | 1,737,046,000USD | 1,447,064,000USD |
| Unclassified Non Current Assets | 523,328,000USD | 105,439,000USD | 66,564,000USD | -100,806,000USD | -174,115,000USD | 68,206,000USD | — | 373,335,000USD |
| Unclassified Current Liabilities | -96,606,000USD | -119,413,000USD | -124,656,000USD | 122,374,000USD | 122,624,000USD | 74,974,000USD | 83,794,000USD | 97,617,000USD |
| Unclassified Non Current Liabilities | 390,917,000USD | 391,916,000USD | 384,744,000USD | 387,500,000USD | 368,064,000USD | 362,675,000USD | 372,464,000USD | 358,126,000USD |
| Unclassified Equity | -443,489,000USD | -298,069,000USD | -161,820,000USD | — | — | 58,341,000USD | 100,554,000USD | 122,749,000USD |
| Other Assets | — | 339,016,000USD | 373,886,000USD | 438,958,000USD | 308,389,000USD | 309,848,000USD | 414,241,000USD | — |
| Cash And Equivalents | — | 1,417,069,000USD | 1,383,848,000USD | 1,209,450,000USD | 932,711,000USD | 521,944,000USD | 426,361,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 1,523,293,000USD | 1,400,723,000USD | 1,020,951,000USD | 897,556,000USD | 779,437,000USD | 474,505,000USD | 621,674,000USD | 404,592,000USD |
| Depreciation | 201,342,000USD | 235,811,000USD | 216,209,000USD | 197,562,000USD | 193,841,000USD | 191,518,000USD | 181,373,000USD | 150,795,000USD |
| Stock Based Compensation | 104,348,000USD | 91,661,000USD | 80,184,000USD | 71,142,000USD | 65,257,000USD | 63,927,000USD | 57,559,000USD | 52,073,000USD |
| Other Non Cash Items | 51,089,000USD | 6,655,000USD | 39,132,000USD | -11,050,000USD | 20,688,000USD | 8,673,000USD | -7,000USD | -286,000USD |
| Change To Account Receivables | -96,778,000USD | -76,684,000USD | -134,278,000USD | -106,511,000USD | 19,346,000USD | -129,195,000USD | 54,383,000USD | -18,013,000USD |
| Change To Inventory | -9,920,000USD | -80,165,000USD | 172,203,000USD | -248,833,000USD | -311,681,000USD | -21,954,000USD | -69,881,000USD | -84,188,000USD |
| Change To Liabilities | 172,715,000USD | — | — | 31,342,000USD | -247,632,000USD | 210,708,000USD | -23,424,000USD | -27,278,000USD |
| Change In Working Capital | -74,243,000USD | 16,738,000USD | 44,784,000USD | -462,127,000USD | -708,076,000USD | 1,405,000USD | -97,921,000USD | -177,054,000USD |
| Operating Cash Flow | 1,805,829,000USD | — | — | — | — | — | — | — |
| Capital Expenditures | -156,285,000USD | -89,865,000USD | -114,856,000USD | -134,000,000USD | -156,036,000USD | -116,826,000USD | -105,938,000USD | -77,342,000USD |
| Net Investments | -25,784,000USD | — | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | -363,130,000USD | 54,381,000USD | 130,252,000USD | 1,159,845,000USD | -42,784,000USD | 158,462,000USD | 10,608,000USD | -942,751,000USD |
| Investing Cash Flow | -545,199,000USD | — | — | — | — | — | — | — |
| Net Debt Issuance | -10,000,000USD | — | — | — | — | — | — | — |
| Common Stock Issuance | 74,503,000USD | — | — | — | — | — | — | — |
| Net Common Stock Issuance | -647,367,000USD | — | — | — | — | — | — | — |
| Common Dividends Paid | -349,662,000USD | — | — | — | — | — | — | — |
| Financing Cash Flow | -1,007,029,000USD | — | — | — | — | — | — | — |
| Effect Of Forex Changes On Cash | 6,183,000USD | — | — | — | — | — | — | — |
| Change In Cash | 259,784,000USD | 971,089,000USD | 10,470,000USD | -45,819,000USD | -21,568,000USD | -167,878,000USD | 316,028,000USD | -41,573,000USD |
| End Cash Flow | 1,469,234,000USD | — | — | — | — | — | — | — |
| Total Cash From Operating Activities | — | 1,751,588,000USD | 1,401,260,000USD | 693,299,000USD | 351,147,000USD | 736,718,000USD | 802,255,000USD | 459,051,000USD |
| Free Cash Flow | — | 1,661,723,000USD | 1,286,404,000USD | 559,299,000USD | 195,111,000USD | 619,892,000USD | 696,317,000USD | 381,709,000USD |
| Investments | — | -200,045,000USD | -269,784,000USD | -1,159,845,000USD | -13,922,000USD | -158,462,000USD | -46,013,000USD | -46,981,000USD |
| Total Cashflows From Investing Activities | — | -200,045,000USD | -269,784,000USD | -1,159,845,000USD | -229,918,000USD | -158,462,000USD | -179,861,000USD | -1,075,706,000USD |
| Net Borrowings | — | -40,000,000USD | -730,000,000USD | 665,000,000USD | 122,000,000USD | -522,000,000USD | -94,012,000USD | 807,485,000USD |
| Total Cash From Financing Activities | — | -606,253,000USD | -1,119,287,000USD | 422,874,000USD | -128,363,000USD | -764,632,000USD | -317,286,000USD | 580,643,000USD |
| Dividends Paid | — | -310,880,000USD | -282,320,000USD | -258,276,000USD | -245,341,000USD | -226,713,000USD | -225,093,000USD | -211,712,000USD |
| Sale Purchase Of Stock | — | -300,025,000USD | -150,011,000USD | 1,070,000,000USD | 47,384,000USD | 90,000,000USD | 1,190,000,000USD | -22,844,000USD |
| Issuance Of Capital Stock | — | 74,439,000USD | 53,094,000USD | 49,142,000USD | 47,384,000USD | 37,790,000USD | 48,182,000USD | 36,727,000USD |
| Begin Period Cash Flow | — | 238,361,000USD | 227,891,000USD | 273,710,000USD | 295,278,000USD | 463,156,000USD | 147,128,000USD | 188,701,000USD |
| End Period Cash Flow | — | 1,209,450,000USD | 238,361,000USD | 227,891,000USD | 273,710,000USD | 295,278,000USD | 463,156,000USD | 147,128,000USD |
| Other Cashflows From Investing Activities | — | 35,484,000USD | -15,396,000USD | -1,025,845,000USD | -17,176,000USD | -41,636,000USD | -38,518,000USD | -8,632,000USD |
| Other Cashflows From Financing Activities | — | -29,787,000USD | -10,050,000USD | -32,992,000USD | 235,594,000USD | -53,709,000USD | -46,363,000USD | -29,013,000USD |
| Unclassified Financing Cash Flow | — | 74,439,000USD | 53,094,000USD | -1,020,858,000USD | -288,000,000USD | -52,210,000USD | -1,141,818,000USD | 36,727,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | 10,920,000USD | -5,561,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | — | 316,028,000USD | -41,573,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | 39,577,000USD | 28,931,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 398,732,000USD | 392,593,000USD | 348,536,000USD | 379,705,000USD | 365,041,000USD | 344,622,000USD | 311,355,000USD | 292,237,000USD |
| Depreciation | 69,032,000USD | 62,330,000USD | 57,669,000USD | 74,288,000USD | 51,911,000USD | 55,902,000USD | 53,710,000USD | 54,754,000USD |
| Stock Based Compensation | 26,792,000USD | 28,938,000USD | 21,160,000USD | 24,751,000USD | 24,120,000USD | 22,634,000USD | 20,156,000USD | 21,392,000USD |
| Other Non Cash Items | -57,464,000USD | -1,821,000USD | 4,701,000USD | 50,353,000USD | 5,311,000USD | -173,935,000USD | -283,000USD | 14,606,000USD |
| Change To Account Receivables | -16,857,000USD | -72,682,000USD | 29,970,000USD | -5,215,000USD | -40,033,000USD | -67,853,000USD | 36,417,000USD | -57,523,000USD |
| Change To Inventory | 12,480,000USD | 26,129,000USD | -14,663,000USD | -32,133,000USD | 29,864,000USD | -7,641,000USD | -70,254,000USD | 8,909,000USD |
| Change In Working Capital | 117,040,000USD | -142,295,000USD | 25,255,000USD | 9,669,000USD | 132,278,000USD | 59,400,000USD | -59,400,000USD | 57,125,000USD |
| Total Cash From Operating Activities | 554,132,000USD | 339,745,000USD | 457,321,000USD | 538,766,000USD | 578,661,000USD | 308,623,000USD | 325,538,000USD | 440,114,000USD |
| Capital Expenditures | -33,654,000USD | -34,555,000USD | -42,965,000USD | -30,585,000USD | -23,788,000USD | -18,877,000USD | -19,607,000USD | -26,323,000USD |
| Free Cash Flow | 520,478,000USD | 305,190,000USD | 414,356,000USD | 508,181,000USD | 554,873,000USD | 289,746,000USD | 305,931,000USD | 413,791,000USD |
| Investments | 6,444,000USD | -16,387,000USD | -52,578,000USD | -133,713,000USD | -31,786,000USD | -36,692,000USD | 2,146,000USD | -46,509,000USD |
| Total Cashflows From Investing Activities | -58,028,000USD | -50,942,000USD | -52,578,000USD | -133,713,000USD | -31,786,000USD | -36,692,000USD | 2,146,000USD | -46,509,000USD |
| Net Borrowings | 0USD | -5,000,000USD | 0USD | -5,000,000USD | 0USD | -5,000,000USD | -30,000,000USD | — |
| Total Cash From Financing Activities | -255,242,000USD | -258,349,000USD | -230,274,000USD | -163,887,000USD | -144,071,000USD | -147,538,000USD | -150,757,000USD | -393,283,000USD |
| Dividends Paid | -87,238,000USD | -87,584,000USD | -87,750,000USD | -77,590,000USD | -77,704,000USD | -77,695,000USD | -77,891,000USD | -70,553,000USD |
| Sale Purchase Of Stock | -175,013,000USD | -175,014,000USD | -150,010,000USD | -100,008,000USD | -75,026,000USD | -74,986,000USD | -50,005,000USD | -50,004,000USD |
| Issuance Of Capital Stock | 7,427,000USD | 29,557,000USD | 8,205,000USD | 30,156,000USD | 9,023,000USD | 26,877,000USD | 8,383,000USD | 27,695,000USD |
| Change In Cash | 243,444,000USD | 33,221,000USD | 174,398,000USD | 276,739,000USD | 410,767,000USD | 95,583,000USD | 188,000,000USD | 451,000USD |
| Begin Period Cash Flow | 1,417,069,000USD | 1,383,848,000USD | 1,209,450,000USD | 932,711,000USD | 521,944,000USD | 426,361,000USD | 238,361,000USD | 237,910,000USD |
| End Period Cash Flow | 1,660,513,000USD | 1,417,069,000USD | 1,383,848,000USD | 1,209,450,000USD | 932,711,000USD | 521,944,000USD | 426,361,000USD | 238,361,000USD |
| Other Cashflows From Investing Activities | 20,641,000USD | -6,016,000USD | -6,918,000USD | 40,406,000USD | -2,992,000USD | 8,725,000USD | -1,767,000USD | 1,834,000USD |
| Other Cashflows From Financing Activities | -418,000USD | -20,308,000USD | -719,000USD | -11,445,000USD | -364,000USD | -16,734,000USD | -1,244,000USD | -421,000USD |
| Unclassified Investing Cash Flow | -51,459,000USD | 6,016,000USD | 49,883,000USD | -9,821,000USD | 26,780,000USD | 10,152,000USD | 21,374,000USD | 24,489,000USD |
| Unclassified Financing Cash Flow | 7,427,000USD | 29,557,000USD | 8,205,000USD | 30,156,000USD | 9,023,000USD | 26,877,000USD | 8,383,000USD | -272,305,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
AirView Cloud-Connected Patient Installed Base
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 35,000,000 | patients | Disclosure |
Countries with Product Sales
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 140 | countries | Disclosure |
Employee Headcount
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 11,370 | employees | Disclosure |
Employees in Asia
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 31 | percent | Disclosure |
Employees in Asia
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 3,560 | employees | Disclosure |
Employees in Australia
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 15 | percent | Disclosure |
Employees in Australia
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 1,650 | employees | Disclosure |
Employees in Cost of Sales Activities
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 4,590 | employees | Disclosure |
Employees in Europe
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 2,670 | employees | Disclosure |
Employees in Europe
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 23 | percent | Disclosure |
Employees in Research and Development
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 2,300 | employees | Disclosure |
Employees in Sales, Marketing and Administration
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 4,480 | employees | Disclosure |
Employees in the Americas
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 3,490 | employees | Disclosure |
Employees in the Americas
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 31 | percent | Disclosure |
Patients Registered to myAir
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 12,000,000 | registered patients | Disclosure |
Residential Care Software Patient Accounts Supported
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 180,000,000 | individual patient accounts | Disclosure |
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q3 2026Quarterly · 2026-03-31 | Product | Residential Care Software | 170,890,000 | USD | 0000943819-26-000025 |
| Q3 2026Quarterly · 2026-03-31 | Product | Sleep And Breathing Health | 1,260,516,000 | USD | 0000943819-26-000025 |
| Q3 2026Quarterly · 2026-03-31 | Segment | Residential Care Software | 170,890,000 | USD | 0000943819-26-000025 |
| Q3 2026Quarterly · 2026-03-31 | Segment | Sleep And Breathing Health | 1,260,516,000 | USD | 0000943819-26-000025 |
| Q2 2026Quarterly · 2025-12-31 | Product | Residential Care Software | 166,870,000 | USD | 0000943819-26-000007 |
| Q2 2026Quarterly · 2025-12-31 | Product | Sleep And Breathing Health | 1,255,938,000 | USD | 0000943819-26-000007 |
| Q2 2026Quarterly · 2025-12-31 | Segment | Residential Care Software | 166,870,000 | USD | 0000943819-26-000007 |
| Q2 2026Quarterly · 2025-12-31 | Segment | Sleep And Breathing Health | 1,255,938,000 | USD | 0000943819-26-000007 |
| Q1 2026Quarterly · 2025-09-30 | Product | Residential Care Software | 166,136,000 | USD | 0000943819-25-000090 |
| Q1 2026Quarterly · 2025-09-30 | Product | Sleep And Breathing Health | 1,169,446,000 | USD | 0000943819-25-000090 |
| Q1 2026Quarterly · 2025-09-30 | Segment | Residential Care Software | 166,136,000 | USD | 0000943819-25-000090 |
| Q1 2026Quarterly · 2025-09-30 | Segment | Sleep And Breathing Health | 1,169,446,000 | USD | 0000943819-25-000090 |
| Q4 2025Quarterly · 2025-06-30 | Product | Residential Care Software | 167,008,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Product | Sleep And Breathing Health | 1,180,985,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Segment | Residential Care Software | 167,008,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Segment | Sleep And Breathing Health | 1,180,985,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-06-30 | Geography | Rest of World | 1,860,746,000 | USD | 0000943819-25-000035 |
| FY 2025Yearly · 2025-06-30 | Geography | United States | 3,285,581,000 | USD | 0000943819-25-000035 |
| FY 2025Yearly · 2025-06-30 | Product | Residential Care Software | 641,437,000 | USD | 0000943819-25-000035 |
| FY 2025Yearly · 2025-06-30 | Product | Sleep And Breathing Health | 4,504,890,000 | USD | 0000943819-25-000035 |
| FY 2025Yearly · 2025-06-30 | Segment | Residential Care Software | 641,437,000 | USD | 0000943819-25-000035 |
| FY 2025Yearly · 2025-06-30 | Segment | Sleep And Breathing Health | 4,504,890,000 | USD | 0000943819-25-000035 |
| Q3 2025Quarterly · 2025-03-31 | Product | Residential Care Software | 161,161,000 | USD | 0000943819-26-000025 |
| Q3 2025Quarterly · 2025-03-31 | Product | Sleep And Breathing Health | 1,130,575,000 | USD | 0000943819-26-000025 |
| Q3 2025Quarterly · 2025-03-31 | Segment | Residential Care Software | 161,161,000 | USD | 0000943819-26-000025 |
| Q3 2025Quarterly · 2025-03-31 | Segment | Sleep And Breathing Health | 1,130,575,000 | USD | 0000943819-26-000025 |
| Q2 2025Quarterly · 2024-12-31 | Product | Residential Care Software | 156,496,000 | USD | 0000943819-26-000007 |
| Q2 2025Quarterly · 2024-12-31 | Product | Sleep And Breathing Health | 1,125,593,000 | USD | 0000943819-26-000007 |
| Q2 2025Quarterly · 2024-12-31 | Segment | Residential Care Software | 156,496,000 | USD | 0000943819-26-000007 |
| Q2 2025Quarterly · 2024-12-31 | Segment | Sleep And Breathing Health | 1,125,593,000 | USD | 0000943819-26-000007 |
| Q1 2025Quarterly · 2024-09-30 | Product | Residential Care Software | 156,772,000 | USD | 0000943819-25-000090 |
| Q1 2025Quarterly · 2024-09-30 | Product | Sleep And Breathing Health | 1,067,737,000 | USD | 0000943819-25-000090 |
| Q1 2025Quarterly · 2024-09-30 | Segment | Residential Care Software | 156,772,000 | USD | 0000943819-25-000090 |
| Q1 2025Quarterly · 2024-09-30 | Segment | Sleep And Breathing Health | 1,067,737,000 | USD | 0000943819-25-000090 |
| Q4 2024Quarterly · 2024-06-30 | Product | Residential Care Software | 151,938,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-06-30 | Product | Sleep And Breathing Health | 1,071,257,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-06-30 | Segment | Residential Care Software | 151,938,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-06-30 | Segment | Sleep And Breathing Health | 1,071,257,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-06-30 | Geography | Rest of World | 1,705,244,000 | USD | 0000943819-25-000035 |
| FY 2024Yearly · 2024-06-30 | Geography | United States | 2,980,053,000 | USD | 0000943819-25-000035 |
| FY 2024Yearly · 2024-06-30 | Product | Residential Care Software | 584,125,000 | USD | 0000943819-25-000035 |
| FY 2024Yearly · 2024-06-30 | Product | Sleep And Breathing Health | 4,101,172,000 | USD | 0000943819-25-000035 |
| FY 2024Yearly · 2024-06-30 | Segment | Residential Care Software | 584,125,000 | USD | 0000943819-25-000035 |
| FY 2024Yearly · 2024-06-30 | Segment | Sleep And Breathing Health | 4,101,172,000 | USD | 0000943819-25-000035 |
| FY 2023Yearly · 2023-06-30 | Geography | Rest of World | 1,503,070,000 | USD | 0000943819-25-000035 |
| FY 2023Yearly · 2023-06-30 | Geography | United States | 2,719,923,000 | USD | 0000943819-25-000035 |
| FY 2023Yearly · 2023-06-30 | Product | Residential Care Software | 497,976,000 | USD | 0000943819-25-000035 |
| FY 2023Yearly · 2023-06-30 | Product | Sleep And Breathing Health | 3,725,017,000 | USD | 0000943819-25-000035 |
| FY 2023Yearly · 2023-06-30 | Segment | Residential Care Software | 497,976,000 | USD | 0000943819-25-000035 |
| FY 2023Yearly · 2023-06-30 | Segment | Sleep And Breathing Health | 3,725,017,000 | USD | 0000943819-25-000035 |
| FY 2022Yearly · 2022-06-30 | Product | Sleep And Respiratory | 3,177,298,000 | USD | 0000943819-24-000013 |
| FY 2022Yearly · 2022-06-30 | Product | Software As AService | 400,829,000 | USD | 0000943819-24-000013 |
| FY 2022Yearly · 2022-06-30 | Segment | Sleep And Respiratory | 3,177,298,000 | USD | 0000943819-24-000013 |
| FY 2022Yearly · 2022-06-30 | Segment | Software As AService | 400,829,000 | USD | 0000943819-24-000013 |
| FY 2021Yearly · 2021-06-30 | Product | Sleep And Respiratory | 2,823,235,000 | USD | 0000943819-23-000011 |
| FY 2021Yearly · 2021-06-30 | Product | Software As AService | 373,590,000 | USD | 0000943819-23-000011 |
| FY 2021Yearly · 2021-06-30 | Segment | Devices And Masks | 2,823,235,000 | USD | 0000943819-23-000011 |
| FY 2021Yearly · 2021-06-30 | Segment | Software As AService | 373,590,000 | USD | 0000943819-23-000011 |
| FY 2020Yearly · 2020-06-30 | Product | Sleep And Respiratory | 2,602,381,000 | USD | 0000943819-22-000010 |
| FY 2020Yearly · 2020-06-30 | Product | Software As Service | 354,632,000 | USD | 0000943819-22-000010 |
| FY 2020Yearly · 2020-06-30 | Segment | Devices And Masks | 2,602,381,000 | USD | 0000943819-22-000010 |
| FY 2020Yearly · 2020-06-30 | Segment | Software As Service | 354,632,000 | USD | 0000943819-22-000010 |
| FY 2019Yearly · 2019-06-30 | Product | Sleep And Respiratory | 2,330,783,000 | USD | 0000943819-21-000017 |
| FY 2019Yearly · 2019-06-30 | Product | Software As Service | 275,789,000 | USD | 0000943819-21-000017 |
| FY 2018Yearly · 2018-06-30 | Geography | Rest of World | 994,984,000 | USD | 0000943819-18-000013 |
| FY 2018Yearly · 2018-06-30 | Geography | United States | 1,345,212,000 | USD | 0000943819-18-000013 |
| FY 2018Yearly · 2018-06-30 | Product | Sleep And Respiratory | 2,183,193,000 | USD | 0000943819-20-000013 |
| FY 2018Yearly · 2018-06-30 | Product | Software As Service | 157,003,000 | USD | 0000943819-20-000013 |
| FY 2017Yearly · 2017-06-30 | Geography | Germany | 153,283,000 | USD | 0001193125-17-248016 |
| FY 2017Yearly · 2017-06-30 | Geography | Rest of World | 684,258,000 | USD | 0001193125-17-248016 |
| FY 2017Yearly · 2017-06-30 | Geography | United States | 1,229,196,000 | USD | 0001193125-17-248016 |
| FY 2016Yearly · 2016-06-30 | Geography | France | 136,847,000 | USD | 0001193125-16-673607 |
| FY 2016Yearly · 2016-06-30 | Geography | Germany | 163,257,000 | USD | 0001193125-16-673607 |
| FY 2016Yearly · 2016-06-30 | Geography | North And Latin America | 1,130,431,000 | USD | 0001193125-16-673607 |
| FY 2016Yearly · 2016-06-30 | Geography | Rest of World | 408,178,000 | USD | 0001193125-16-673607 |
| FY 2015Yearly · 2015-06-30 | Geography | Australia | 42,174,000 | USD | 0001193125-15-281887 |
| FY 2015Yearly · 2015-06-30 | Geography | France | 145,504,000 | USD | 0001193125-15-281887 |
| FY 2015Yearly · 2015-06-30 | Geography | Germany | 184,245,000 | USD | 0001193125-15-281887 |
| FY 2015Yearly · 2015-06-30 | Geography | North And Latin America | 962,696,000 | USD | 0001193125-15-281887 |
| FY 2015Yearly · 2015-06-30 | Geography | Rest of World | 344,293,000 | USD | 0001193125-15-281887 |
| FY 2014Yearly · 2014-06-30 | Geography | Australia | 33,379,000 | USD | 0001193125-15-281887 |
| FY 2014Yearly · 2014-06-30 | Geography | France | 152,271,000 | USD | 0001193125-15-281887 |
| FY 2014Yearly · 2014-06-30 | Geography | Germany | 214,598,000 | USD | 0001193125-15-281887 |
| FY 2014Yearly · 2014-06-30 | Geography | North And Latin America | 839,126,000 | USD | 0001193125-15-281887 |
| FY 2014Yearly · 2014-06-30 | Geography | Rest of World | 315,599,000 | USD | 0001193125-15-281887 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.